When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
Aloe Blacc’s fame means nothing in biotech (and that’s the point)
Originally reported by TechCrunch. Read the full story at the original source.
Related Articles
CloudNC raises $20M to automate manufacturing’s most pressing bottlenecks
UK-based manufacturing software startup CloudNC announced a $20 million B extension round on Wednesday, bringing its lif...
How to change and customize your Apple CarPlay display
CarPlay doesn't have a ton of customization options, but it's worth going through what's there to set it up ...
Meta continues to run ads promoting child sexual abuse material in India - report
Image source, Getty ImagesImage caption, Tech Transparency Project (TTP) says it found 332 adverts with CSAM that ran on...
White House takes down ‘Build the Wall’ game after the Tetris Company complains
A video game posted to the Trump administration’s website — one that closely resembled Tetris — has been take...